National Health Act 1953 Declaration under subsection 85(2AA) (No. PB 2 of 2000) (Cth)

COMMONWEALTH OF AUSTRALIA

National Health Act 1953

PHARMACEUTICAL BENEFITS

DECLARATION UNDER SUBSECTION 85 (2AA)

No. PB 2 of 2000

I, ALAN WILLIAM STEVENS, Acting Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Aged Care and Delegate of the Minister for Health and Aged Care, having in accordance with subsection 85 (2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85 (2AA) of the National Health Act 1953, hereby make the following Declaration:

1. This Declaration shall come into operation on 1 February 2000.

1. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.

THE SCHEDULE

Grepafloxacin Hydrochloride Sesquihydrate

Omeprazole and Metronidazole and Amoxycillin Trihydrate

“RVHB Maxamaid”

Vidarabine

_____________________________________________________________________

Dated this 31^st day of December 1999.

ALAN WILLIAM STEVENS

Acting Assistant Secretary

Pharmaceutical Benefits Branch

Department of Health and Aged Care

Delegate of the Minister for Health and Aged Care